CAERUS CONSULTING AS
Operating
Produktutvikling i farmasøytisk industri,
konsulentvirksomhet samt deltakelse i andre foretak.
Utvikling av nye legemidler innenfor gruppen antibiotika.
Links
Organization
- Chairman of the board
- TV
Torgeir Vaage1964
- Years since formation
- 17 years
- since May 9, 2009
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 10
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 6,007,044
- NOK
- Annual total result 2025
- 3,920,831
- NOK
- Total equity 2025
- 12,074,459
- NOK
Last update: May 6, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
TV 1964 | Chairman | - |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
VT 1964 | - | 100 % directly |
Last update: Apr 1, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
VT 1964 | Ordinary shares | 10 | 100 % |
Shares owned by the CAERUS CONSULTING AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 9 | < 0.01 % | |
A Closed | Ordinary shares | 5,000 | < 0.01 % |
| Ordinary shares | 500 | < 0.01 % | |
| Ordinary shares | 10,000 | < 0.01 % | |
| Ordinary shares | 1,000 | < 0.01 % | |
| Ordinary shares | 500 | < 0.01 % | |
| Ordinary shares | 75,000 | < 0.01 % | |
| Ordinary shares | 500 | < 0.01 % | |
| Ordinary shares | 25,000 | < 0.01 % | |
| Ordinary shares | 1,150 | < 0.01 % | |
| Ordinary shares | 10,000 | < 0.01 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 6,007,044 | 4,316,759 | 5,096,950 | 5,421,733 |
Annual Total Result | 3,920,831 | 2,434,379 | 3,789,421 | 4,253,937 |
Total assets | 13,661,368 | 10,663,857 | 7,961,490 | 6,206,051 |
Total liabilities | 1,586,909 | 910,229 | 242,242 | 1,276,223 |
Total equity | 12,074,459 | 9,753,628 | 7,719,249 | 4,929,828 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 6,007,044 | 4,316,759 | 5,096,950 | 5,421,733 |
Total operating costs | 1,853,018 | 1,451,806 | 1,339,405 | 1,507,718 |
Operating result | 4,154,026 | 2,864,953 | 3,757,545 | 3,914,015 |
Financial income/costs | 713,050 | 237,104 | 61,310 | 339,923 |
Profit before tax | 4,867,076 | 3,102,057 | 3,818,856 | 4,253,937 |
Total tax & extraordinary income/cost | 946,245 | 667,678 | 29,435 | 0 |
Annual Total Result | 3,920,831 | 2,434,379 | 3,789,421 | 4,253,937 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 1,042,338 | 1,042,338 | 418,228 | 418,228 |
Total current assets | 12,619,030 | 9,621,519 | 7,543,262 | 5,787,823 |
Total assets | 13,661,368 | 10,663,857 | 7,961,490 | 6,206,051 |
Short term debt | 1,586,909 | 910,229 | 242,242 | 1,276,223 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 1,586,909 | 910,229 | 242,242 | 1,276,223 |
Contributed capital | 446,404 | 446,404 | 846,404 | 1,846,404 |
Retained earnings | 11,628,055 | 9,307,224 | 6,872,845 | 3,083,424 |
Total equity | 12,074,459 | 9,753,628 | 7,719,249 | 4,929,828 |
Total equity and liabilities | 13,661,368 | 10,663,857 | 7,961,490 | 6,206,051 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification